DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
about
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskA new biological marker candidate in female reproductive system diseases: Matrix metalloproteinase with thrombospondin motifs (ADAMTS)Genome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chickenCancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.Targeting HOX and PBX transcription factors in ovarian cancer.Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.Epigenetic Pathways in Human Disease: The Impact of DNA Methylation on Stress-Related Pathogenesis and Current Challenges in Biomarker Development.Genomic aberrations in borderline ovarian tumors.DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset.Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors.HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherinIdentification of novel methylation markers in hepatocellular carcinoma using a methylation arrayEpigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.Identifying multi-layer gene regulatory modules from multi-dimensional genomic data.Association between RASSF1A promoter methylation and ovarian cancer: a meta-analysis.Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.Adaptation of ovarian cancer cells to the peritoneal environment: Multiple mechanisms of the developmental patterning gene HOXA9CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.Methylation of tumor suppressor genes in ovarian cancer.Promoter methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma.Progesterone acts via the progesterone receptor to induce adamts proteases in ovarian cancer cells.Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelDNA methylation: its role in cancer development and therapy.Characterization of the Methylation Status of Pax7 and Myogenic Regulator Factors in Cell Myogenic DifferentiationEpigenetic and genetic features of 24 colon cancer cell linesHypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer.An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder CancerTumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution.Importance of spondin 1 and cellular retinoic acid binding protein 1 in the clinical diagnosis of ovarian cancerDNA Methylation of Cellular Retinoic Acid-Binding Proteins in Cervical Cancer.Role of epigenomics in ovarian and endometrial cancers.Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation.Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy.
P2860
Q26799669-7AFC6AC0-07F8-47C7-A0A4-7AA78A988875Q26852045-DAC13E51-5FBE-4C1F-8532-B41B91C86ECDQ28384038-FD665C16-3497-42FB-B09C-9931F036DBEAQ33509293-BCE49E8E-5C86-4669-A6FA-54D52F312465Q33539413-7551849E-ACFC-424B-89CE-C1FB959FE395Q33575005-C3C967C0-1AB4-4BE0-9948-3216B11907FDQ33603731-325DFD42-D6FD-4D80-9022-7EFDB46AE4D3Q33728834-8E0B0E5F-E023-4836-8D23-EAA07D688C92Q33754380-AA62E65B-B45C-4805-9227-AAFF124559B4Q33784600-6DC15C96-D77D-4379-9838-C73242765C52Q33815755-2BEF5153-A027-4DDF-97E9-63F24D0AD438Q33908446-D181AA56-CCDB-4119-96BF-DB6D61F02309Q33917646-BD982190-E23B-42A3-9A7F-44987F892CCBQ33927161-BD98D315-F34C-49D2-95F2-B688946C0F8DQ34014744-352E316A-8B0F-4E9E-ACC9-6FD675369A49Q34234670-8F099C11-6E4F-46BF-8660-6ECD8F83AB19Q34366411-03101157-2606-4A6B-A559-28322F8565CDQ35014881-0B0E0DEF-A498-4DCE-9A7C-0914BB55971BQ35172269-2445395A-92D1-4F0B-BAD5-E3688304DFC9Q35179223-88E57B82-3664-433F-9268-225C1CBE59A9Q35447606-968C0642-DB5F-4F80-81DE-7D652E1C0056Q35623134-5691E2D8-041B-4137-B22C-CA634567E1B2Q35817482-4397362D-5221-4479-AFBE-6BA3B6873B85Q36290268-0EDF6C89-D975-42B3-A198-7C012166306BQ36386613-5E2447BF-E39F-4135-BAE7-581B33DCBCADQ36462879-0B840D35-077E-464C-BEB8-B117CAE85815Q36616455-89C54608-CAC1-41BF-A129-5BF4106A05B5Q36975149-DDC12944-A609-4ABB-B3E0-1B7683869C57Q36986433-3ADA5E61-9C88-4A74-B926-25E255AA4DDFQ37064097-05349B5D-1E88-4A2F-AC98-4E90E888C48FQ37275764-890A6458-6E2D-4A58-A191-8A3E5C825D2BQ37286791-5C7BB23F-92B2-44C2-9ACF-166D448C0685Q37290684-16D0BFD5-EA16-48EF-9A96-F41F034D386EQ37347191-8A7B8A28-8486-416C-AC5A-F28C65BA9159Q37349573-FD5D574D-0FEF-47AA-981D-8A62AEFF815AQ37409713-9F8A5600-4E87-485D-A23B-5829DB1E4D18Q37961734-A9307A4A-D83A-459E-A2BA-82B63E0727FCQ38630962-99FC6E22-75D2-4070-ADAC-075E69E9ECB4Q38743508-72BCF4E5-8D1C-4AF1-994D-304584E597D8Q39243827-B322A214-BCCD-43A3-BF59-179874C134CC
P2860
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@ast
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@en
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@en-gb
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@nl
type
label
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@ast
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@en
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@en-gb
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@nl
prefLabel
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@ast
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@en
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@en-gb
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
DNA methylation profiling of o ...... 1, and CRABP1 as novel targets
@en
P2093
Francesca Micci
Guro E Lind
Ilvars Silins
Qinghua Wu
Terje Ahlquist
Zhenhe Suo
P2860
P2888
P3181
P356
10.1186/1476-4598-6-45
P407
P577
2007-01-01T00:00:00Z
P5875
P6179
1045168903